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GM crops otherwise known as biotech or transgenic crops
have captured the minds of various people and organizations
around the globe, particularly in terms of its potential beneﬁts
and risks associated with it. Over the past decade, GM crop
productions have gradually increased and captured strategic
places both in developed and developing countries. At the
same time intense public debate continues as to whether GM
products are safe due to potential long-term effects on human
health and environments. But no environmental or human
health problems resulting from GM crops have been docu-
mented so far [8,21,28,44,105,107]. Contrary to this debate,
evidence-based reports on health and environment beneﬁts
have been documented [13,34,46,75,92,98,118]. Apart from po-
tential risks, control of food supply as a result of concentration
of industry power is another major concern among the critics
[17]. Given the growing world population with majority living
in developing countries and suffering from hunger and pov-
erty, critics have the right to express their concerns.
This brings about Green Revolution that beneﬁted mostly
Asian and Latin America country in 1960s through the
1980s while African countries were by passed, perhaps the big-
gest failure of Green Revolution. The Green Revolution was
successful to some extent in Asia due to high-yielding varieties
of rice and wheat, chemical inputs, irrigation and improved
crop systems, saving almost 1 billion people from hunger. It
was noticeable in terms of food security, poverty reduction
and increased per capital income [23,104]. After many years
of continuous use of agro-chemicals and irrigation under
Green Revolution regime, serious environmental changes of
soils started, water bodies’ quality was affected, and agricul-
tural yields declined. It was indicated that increased agricul-
tural production from Green Revolution has reached its
limits, thus the need for newer technologies to increase thefood production for rising world population [23]. The applica-
tion of GM technology was acclaimed as Doubly Green Rev-
olution that has a great potential to improve and increase crop
yields [22].
In this review, a wide range of relevant papers that focus on
current issues of GM crops in developing countries were ana-
lysed, and latest information were obtained from the ﬁrst year
of commercialization till date. The data used for the analysis of
commercialization of GM crops between 1996 and 2010 were
obtained from the International Service for the Acquisition
of Agri-Biotech Applications (ISAAA), published annually
by James Clive. ISAAA provides up-to-date database informa-
tion on global cultivation of GM crops since 1996, and how-
ever it does not necessarily represent high quality
information but provides reliable data on GM crops (Personal
communication). This paper is divided into three parts. First
part provides reviewed background to the commercialization
of GM crops production in developing countries while corrob-
orating it with some evidence in developed countries. Second
part discusses the global impact of GM crops that covers the
beneﬁts and potential roles of GM crops in global food secu-
rity and poverty reduction in developing countries. Third part
examines some of the constraints obstructing the progress of
GM technology in developing countries, with policy implica-
tions that highlight and discuss vital points which can facilitate
the development and adoption of GM technology in develop-
ing countries. Finally, this paper ends with concluding remarks
about the observations noticed during the review and how GM
technology can progress for sustainable human development in
developing countries.
2. Commercial production of GM crops in developing countries
The ﬁrst commercial production of GM crops started ofﬁcially
in 1996. Prior to 1996, only China (GM tobacco) and USA
Table 1 The area of GM crops produced globally between 1996 and 2010, by country (million ha).
Country 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
USA 1.5 8.1 20.5 28.7 30.3 35.7 39.0 42.8 47.6 49.8 54.6 57.7 62.5 64.0 66.8
\Argentina 0.1 1.4 4.3 6.7 10.0 11.8 13.5 13.9 16.2 17.1 18.0 19.1 21.0 21.3 22.9
\Brazil – – – – – – – 3.0 5.0 9.4 11.5 15.0 15.8 21.4 25.4
\India – – – – – – /+ 0.1 0.5 1.3 3.8 6.2 7.6 8.4 9.4
Canada 0.1 1.3 2.8 4.0 3.0 3.2 3.5 4.4 5.4 5.8 6.1 7.0 7.6 8.2 8.8
\China 1.1 1.8 /+ 0.3 0.5 1.5 2.1 2.8 3.7 3.3 3.5 3.8 3.8 3.7 3.5
\Paraguay – – – – – – – – 1.2 1.8 2.0 2.6 2.7 2.2 2.6
\Pakistan – – – – – – – – – – – – – – 2.4
\South Africa – – /+ 0.1 0.2 0.2 0.3 0.4 0.5 0.5 1.4 1.8 1.8 2.1 2.2
\Uruguay – – – – /+ /+ /+ /+ 0.3 0.3 0.4 0.5 0.7 0.8 1.1
\Bolivia – – – – – – – – – – – – 0.6 0.8 0.9
Australia /+ 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.3 0.2 0.1 0.2 0.2 0.7
\Phillippines – – – – – – – – 0.1 0.1 0.2 0.3 0.4 0.5 0.5
\Myanmar – – – – – – – – – – – – – – 0.3
\BurkinaFaso – – – – – – – – – – – – /+ 0.1 0.3
Spain – – /+ /+ /+ /+ /+ /+ 0.1 0.1 0.1 0.1 0.1 0.1 0.1
\Mexico /+ /+ /+ /+ /+ /+ /+ /+ 0.1 0.1 0.1 0.1 0.1 0.1 0.1
\Romania – – – /+ /+ /+ /+ /+ 0.1 0.1 0.1 /+ /+ /+ /+
Total 1.7 12.7 27.8 39.9 44.2 52.6 58.5 67.5 81.0 90.0 102.0 114.3 125.0 134.0 148.2
Note: Countries represented in the table are the ones that produced at least more than 50,000 hectares of GM crops in a single year between 1996 and 2010. Minus sign () in the table shows that
country did not grow GM crops in that particular year. Minus and plus sign (/+) show that the country grew less than 0.1 million hectares in that particular year. The countries that were not
represented in the table are the ones that did not grow up to 50,000 hectares in a single year between 1996 and 2010 with the years of commercial GM crop production stated as follows; Colombia
(2002–2010), Chile (2007–2010), Honduras (2002–2010), Portugal (1999, 2005–2010), Czech Republic (2005–2010), Poland (2007–2010), Egypt (2008–2010), Ukraine (1999), France (1998–2000,
2005–2007) Bulgaria (2000–2003), Indonesia (2001–2003), Slovakia (2006–2010), Costa Rica (2009–2010), Iran (2005–2006) Sweden (2010) and Germany (2000–2002, 2005–2008, 2010). The data
shown in the table does not necessarily represent accurate information on commercial production of GM crops between 1996 and 2010 but shows reliable data in the last 15 years of commer-
cialisation. Developing countries according to World Bank list 2010 are represented with symbol (\).
Source: adapted from Refs. [54–67].
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Figure 1 Distribution of resource-poor farmers that planted GM
crops in 2010. The ﬁgure represents the distribution of resource-
poor farmers in developing countries. Of 14.4 million farmers that
cultivated GM crops in 2010, 6.5 million farmers are from China
with an average of 0.6 hectares for GM cotton, and 6.3 million
farmers from India cultivated mainly GM cotton. More than
350,000 farmers cultivated GM cotton for the ﬁrst time in
Pakistan and Myanmar in 2010. Over 250,000 farmers cultivated
GM maize in Philippines, while nearly 100,000 farmers in Burkina
Faso cultivated GM cotton. The remaining 13 developing coun-
tries with 200,000 farmers growing GM crops like GM maize, GM
soybean, GM cotton and GM canola. Source: adapted from [67].
86 A.A. Adenle(GM tomato) are widely known to have planted GM crops for
commercial purposes in 1992 and 1994, respectively [101,117].
Since the commercial production of GM crops started 1996,
steady growth has mostly taken place in developing countries.
Current commercial productions of GM crops are more in
Asia and Latin America countries with few countries in Africa.
There are also few commercial GM crops in North America
but the United States, being the major player has the highest
adoption, and arguably the only country with most advanced
biotechnology research and development (R&D). The Euro-
pean attitude towards GM crops has led to scanty adoption,
while Japan one of the few developed Asian countries has
shown little or no interest. Apart from developed countries,
both Asia and Latin America have relatively high level of
capacity building including functional biosafety regulations
for growing commercial GM crops. These literatures [43,103]
provide some relevant information on status of biotechnology
programs in Asia and Latin America, respectively. Some coun-
tries like India and China in Asia, Argentina and Brazil in La-
tin America have enacted biosafety regulations, while other
countries are working on it. Only few African countries like
South Africa, Egypt and Burkina Faso have functional bio-
safety regulations and capable of producing commercial GM
crops, while majority are at different stages of developing na-
tional biosafety frameworks [71,76].
The year 2010 marked 15th anniversary of commercial pro-
duction of GM crops. 29 countries produced commercial GM
crops with a remarkable record of total global area of 148 mil-
lion hectares since commercialization started in 1996, and
majority of the cultivations took place in developing countries
[67]. Between 1996 and 2010, when 1.7 million hectares and
148 million hectares of GM crops were planted, respectively,
an unprecedented growth of 8, 606% was achieved. This was
a signiﬁcant achievement with 87-fold increase, making it the
fastest crop technology in the history of commercial agricul-
ture [67]. During the 15 years, the number of GM growing
countries increased from 6 in 1996 to 29 in 2010. Of 29 coun-
tries that planted GM crops in 2010, 19 are from developing
countries. Two developing countries like Pakistan and Myan-
mar and the ﬁrst Scandinavian country, Sweden planted GM
crops commercially for the ﬁrst time in 2010.
China and India are the most advanced and dominant GM
crop producers in Asia. Of global total area of 148 million
hectares planted in 2010 (Table 1), China (3.5 million hectares)
and India (9.4 million hectares) planted a combined total area
of 12.9 million hectares. In Asia, China and India represent
45% (34.3 million hectares) and 49% (37.3 million hectares)
respectively of total area of 76.4 million hectares of GM crops
(mostly Bt cotton) planted in 15 years of commercialization
(Table 1). Australia is the only Asia-Paciﬁc country that
planted 0.7 million hectares of GM crops in 2010. Australia
has planted a total area of 2.6 million hectares since commer-
cialization started in 1996 with focus on Bt cotton and HT
canola.
Argentina and Brazil are the most advanced and dominant
GM crop producers in Latin America. Of global total area of
148 million hectares planted in 2010 (Table 1), Argentina (22.9
million hectares) and Brazil (25.4 million hectares) planted a
combined total area of 48.3 million hectares. In Latin America,
Argentina and Brazil represent 61% (197.3 million hectares)
and 33% (106.5 million hectares) respectively of total area of
326 million hectares of GM crops planted in 15 years of com-mercialization with focus on Bt cotton, Bt maize and Bt soy-
bean (Table 1). Argentina is the second highest GM crop
adopter in the world 18% (197.3 million hectares) after United
States 55% (609.6 million hectares) of total global area of 1.1
billion hectares produced between 1996 and 2010.
Of three African countries that grow GM crops commer-
cially, South Africa is the largest producer of GM crops such
as Bt maize, Bt soybean and Bt cotton followed by Burkina
Faso that produces Bt cotton. Of global total area of 148 mil-
lion hectares planted in 2010, South Africa (2.2 million hect-
ares) and Burkina Faso (0.3 million hectares) planted a
combined total area of 2.5 million hectares (Table 1). Egypt
produced less than 50,000 hectares of GM maize since the
country joined GM crops producing countries.
The United States (US) and Canada are the two top pro-
ducers of GM crops in North America. Of global total area
of 148 million hectares planted in 2010, the US (66.8 million
hectares) and Canada (8.8 million hectares) planted a com-
bined total area of 75.6 million hectare (Table 1). The US
alone represents 45% of global total area of 148 million hect-
ares in 2010 and has been the largest adopter in the world since
1996. Spain is the only European country that has been grow-
ing GM crops for over a decade but only became visible in
2004 when the country planted 0.1 million hectares up till
2010 (Table 1), as opposed to 20,000 hectares planted in
1998 the ﬁrst year of commercialisation [55]. A total of 0.7 mil-
lion hectares of GM maize have been grown in Spain over the
past decade, making it the highest adopter in Europe. Other
few European countries planted less than 0.1 million hectare
as described in the Table 1.
The global area of four main GM crops that were grown in
2010 include; 50% Bt soybean (73.3 million hectares), 31% Bt
maize (46.8 million hectares), 14% Bt cotton (21 million hect-
ares) and 5% Bt canola (7 million hectares). In terms of crop
Global capture of crop biotechnology in developing world over a decade 87grown by traits globally, herbicide tolerance of four main GM
crops (Bt soybean, Bt maize, Bt canola and Bt cotton) plus su-
gar beet and alfalfa remains the dominant trait at 63% (89.3
million hectares), followed by insect resistant traits at 17%
(26.3 million hectares). About 15.4 million farmers planted
commercial GM crops around the world in 2010, 94% (14.4
million farmers) are mainly resource poor-farmers from devel-
oping countries with majority of farmers coming from China
(6.5 million farmers) and India (6.3 million farmers) Fig. 1.Table 2 Global farm income beneﬁts of GM crops in
developed and developing countries (million US$, 2008).
GM crops Developed Developing
GM HT soybeans 1232.1 1693.6
GM IR maize 2, 380.5 265.0
GM HT maize 357.4 76.1
GM IR cotton 213.8 2690.8
GM HT cotton 5.5 9.1
GM HT canola 391.8 0
GM virus resistant papaya
and squash and GM HT sugar beet
51.5 0
Total 4632.6 4734.6
Source: [13].3. Global impact of GM crops
3.1. Beneﬁts of GM crops
The global beneﬁt of GM crops since commercialization began
in 1996 has been outstanding, delivering socio-economic, envi-
ronmental and human health beneﬁts to both small and large-
scale farmers in developing and developed countries, respec-
tively. At the same time, beneﬁts of GM crops have been crit-
icised. The literatures on the beneﬁt of GM crops are vast, but
this section of the article has discussed some of the relevant pa-
pers while mentioning others’ data that criticised with mixed
situations.
3.1.1. Yield impact
The yield impact of GM crops varies from country to country
with different literature reports and some of the GM crops
producing countries have been reported. For example, Bt cot-
ton, yield increase is reported as follows; 0% in Australia [31],
7–15% in China [49], 9–11% in USA [11], 20% in Mexico
[113], 32–34% in Argentina [95], 40–70% in South Africa
[53,80] and 43–87% in India [98]. The United States, South
Africa and Spain represent 5–8% [111], 11% [37] and 4.7%
[36], respectively, for yield increase in Bt maize. In USA,
Argentina and Romania, the yield increase for Bt soybean rep-
resent 2% to 2% [7,11], 0% [97] and 31% [9], respectively.
The literature report on Bt soybean shows little or no yield
gains but signiﬁcant yield increase in Romania may be due
to poor control of weed with introduction of HT soybean
resulting to less damage on crop [9]. According to the literature
evidence as described above, most developing countries have
been shown to have increased yields in Bt cotton compared
to developed countries. While relative increase in yields have
been recorded for GM crops particularly in developing coun-
tries [14,47,94,98], others’ data [38,45,106] have argued that
potential of GM crops in developing countries have too little
substantial yield effects especially in regions with rapid growth
population.
3.1.2. Farm level impact
Some of detailed assessment carried out by Brookes and Bar-
foot [10] for the ﬁrst 13 years of commercialization (1996–
2008) is based on farm level economic effects and the produc-
tion effects. According to Brookes and Barfoot assessment
[10], adoption of GM technology for commercialization has
dramatically improved agricultural production with a positive
impact on farm income, accounting for an increase of US$ 52
billion since 1996. Based on their estimate, increase in farm in-
come beneﬁt for the GM crops such as Bt soybean, Bt maize,
Bt cotton, Bt canola and others represent 5.7% added to the
total value of global production in GM adopting countriesin 2008. Also, in the year 2008, the division of economic ben-
eﬁts in developing countries relative to developed countries as
obtained by the farmers was estimated. As shown in Table 2,
the result showed that the developing countries farmers (pre-
dominantly from all countries in South America, Mexico,
Honduras, Burkina Faso, India, China, Philippines and South
Africa) obtained 50.5% of income farm beneﬁts and the cumu-
lative farm income gain was estimated to be 50% (US$ 26.2
billion). In terms of production impact, the use of GM technol-
ogy has contributed considerably to global production of corn
(79.7 million tonnes), soybean (74.0 million tonnes), cotton
(8.6 million tonnes) and canola (4.8 million tonnes) since 1996.
In contrast, Glover [111] argues that beneﬁts of GM crops
are not uniform and inconsistent due to obvious variability in
farmer income in India; for example, his report suggests that
only few small-scale farmers beneﬁted from Bt cotton as re-
ﬂected in their incomes. Also, a two years survey of small-
holder farmer in South Africa by Thirstle et al. [112] claim
that the amount of labour required to grow Bt cotton is exag-
gerated and that time and labour to grow Bt cotton did not
change. Qayum and Sakkhari [99] report that social and eco-
nomic forces will inﬂuence the GM technology, and as a result
little or no resource-poor farmers will beneﬁt from Bt cotton
adoption in India. As stated by Herring [45] that: ‘‘Bt cottons
have been in the ﬁeld too short a time for deﬁnitive assessment
of either biological or economics success across so varied an
agro-ecology as India; results vary with seasonal variations
of pests, weather and local agronomics’’.
3.1.3. Proﬁtability impact
GM crops have enhanced increase in yield and proﬁtability.
Carpenter [14] analysed 80 examples of GM crops proﬁtability,
59 showed an increase with GM crops with a decrease of 14
and 7 showed no difference. In terms of yields, increase in
proﬁtability was higher in developing countries than developed
countries, especially in GM cotton. For example, the United
States and Australia have an average increase in gross margin,
representing US$ 58/ha and US$ 66/ha, respectively, whereas
China, Mexico, India, South Africa and Argentina have an
average increase in gross margin, representing US$ 470/ha,
US$ 295/ha, US$ 135/ha, US$ 91/ha and US$ 23/ha,
respectively.
Qaim [94] also analysed the difference between developed
and developing countries in term of increase in proﬁtability
for GM maize. The result showed an increase in gross margin
88 A.A. Adenlethat represents US$ 12/ha in the United States, whereas an in-
crease in gross margin in Philippine, South Africa and Argen-
tina represents US$ 53/ha, US$ 42/ha and US$ 20/ha,
respectively, for GM maize. The authors, Carpenter and Qiam
conclude that data only represent the beneﬁt of GM crops
which are greater in developing countries but not the statistical
signiﬁcance of average increases in yield and proﬁtability for
GM crops.
By contrast, Gouse et al. [38] argue that increased yield of
GM varieties was not as a result of GM technology in the case
of Bt and herbicide-tolerant maize in the KwaZulu Natal re-
gion of South Africa. But tillage system was a key factor for
determining the efﬁciency levels, therefore GM technology
only had a minor effect on efﬁciency. In fact the authors, cor-
roborated with statement like ‘‘the results mostly serve to show
how dangerous it is to make any interferences from small sam-
ple surveys in one production season’’.
3.1.4. Environmental impact
The cultivation of GM crops has contributed to reduced pesti-
cide and fuel use, controlling water erosion, preserving soil
structure, lowering tillage operations and green house gas
emission. Reduction in chemical use also lead to reduced cost
that is associated with spraying of pesticide [77]. A study of
environmental impact was examined by Brookes and Barfoot
[10] to assess the amount of pesticide and herbicide applied
on GM crops between 1996 and 2008 using Environmental Im-
pact Quotient (EIQ) indicator. The result showed that the
adoption of GM traits (e.g. GM cotton) have led to reduction
(8.4%) in pesticide application by 352 million kg of active
ingredient with 16.3% drop of environmental impact resulting
from pesticide and herbicide application on crops. This result
suggests that the use of GM crops have had a signiﬁcant posi-
tive impact on the environment, thereby lowering the green-
house gases emission. Moreover, Brookes and Barfoot also
examined the contribution of GM technology in terms of car-
bon sequestration impact; saving of carbon emission due to
reduction in the use of fuel. The report shows that the use of
fuel was reduced for planting GM crops (e.g. GM herbicide
tolerant-HT crops), thereby saving carbon dioxide emission.
For example, 3137 million litres of fuel to equivalent to 8632
million kg was used between 1996 and 2008, compared to
1205 million kg of car equivalent for carbon dioxide saving.
Also, a remarkable ﬁgure of 101,613 million tonnes of carbon
dioxide that could have been released into the atmosphere was
prevented due to carbon saving. Other than Brookes and Bar-
foot data, reductions in pesticide use and costs have been re-
ported in developed countries such as United States,
Australia and Spain [16,94] and developing countries like In-
dia, Mexico, Argentina, China and South Africa
[50,94,96,100]. In addition, a detailed review on positive im-
pact of GM crops on biodiversity in the past 15 years in differ-
ent countries has been reported [15].
3.1.5. Human health impact
Human health beneﬁts due to reduction in pesticide use have
been recorded from the adoption of GM technology, particu-
larly among the farmers without adequate training who are
growing Bt cotton in China [48,92]. In South Africa, introduc-
tion of Bt cotton has led to reduced number of illnesses that is
associated with pesticide applications [5,80]. Moreover, other
ﬁndings have shown that cultivation of GM maize can leadto health beneﬁts. For examples, GM maize contains low
amount of mycotoxins that can cause human disease such as
cancer [115]. And cases like lowering mycotoxins in Bt maize
have also been reported in USA [42,114] and Europe [10,32].
These are cases where low pesticide uses have resulted in re-
duced level of toxicity, thereby reducing the number of poison-
ings among the farmers. In developing countries, mcyotoxins
inspection is poorly controlled when compared to developed
countries, the use of Bt maize can contribute to greater health
beneﬁt among less trained farmers.
3.2. Potential role of GM crops in food security and poverty
reduction in developing countries
GM crops have potential roles towards solving food security
problems and poverty crisis in developing countries, particu-
larly in Africa continent and South East Asia. Global food de-
mand is projected to at least double, and likely to triple, by the
year 2050 when the world population growth is expected to
reach 10 billion people with majority living in developing
countries [30,35]. According to recent statistics estimate by
FAO [29], 925 million people (13%) of 6.3 billion estimated
world population are hungry and undernourished notably in
Asia paciﬁc 9% (578 million) and Africa 4% (239 million).
This evidence suggests that there is still overwhelming shortage
of food production to feed world poor people or perhaps peo-
ple cannot afford the food prices due to high poverty level.
As stated in the new book, the New Harvest in Africa pub-
lished by Juma, that ‘‘global agriculture over the past 40 years
has been characterized by per capita food production growth
of 17 percent and total production up 145 percent’’ [70], which
is not enough for world rapidly growing population particu-
larly in developing countries. And this problem has been
mostly attributed to neglect of agriculture relevant to poor
people by governments and international agencies [29]. There-
fore, food production will have to expand to meet the demand
of growing populations by increasing the agricultural produc-
tion. World food and feed grain production will need to in-
crease by 40% including roots and tubers to increase by
58% so as to meet the projected global food demand in 2020
[89]. GM technology as one of agricultural technologies will
play an important role.
Food security and poverty reduction can be achieved
through GM technology by creating job opportunities, increas-
ing crop productivity, improving nutritional contents, lowering
production costs and food prices [66]. Improving the livelihood
and incomes of people in rural and urban areas is also funda-
mental to food security, since people’s access to food depend
on income. Apart from population growth thatmay likely affect
food security in years to come, problems resulting from abiotic
stresses such as drought, salinity, water-logging, toxic levels or
deﬁciencies of nutrients and biotic stresses due to weeds, insects
anddiseases and climate changewill take a heavy toll of the 5 bil-
lion tons of food currently produced annually, hence a serious
need to tackle these problems.
GM technology can play an important role to achieve eco-
nomic and productivity gains, introduce resistance to pests, in-
sects and diseases for biotic stress, reduce pesticide use,
improve crop tolerance for abiotic stress and enhance the
durability of products during harvesting and shipping
[22,40,110,116]. For example, since commercialization of GM
crops started in 1996, economic gains of US$ 51.9 billion has
Global capture of crop biotechnology in developing world over a decade 89been achieved during period 1996–2008, 50.6% accounts for a
reduction in production cost and 49.6% for substantial yield
gains [66]. While increase in yields and reduction in production
costs are important, food security will be improved much more
effectively by reducing poverty, for example by increasing the
employment rate and household incomes.
In the year 2008, if not for GM crops, 29.6 million metric
tons of increased crop production from four principal GM
crops (10.1 million tons of soybean, 17.1 million tons of maize,
0.6 millions of canola and 1.8 million tons of cotton) would
have required 10.5 million hectares [12,13]. The result suggests
that 29.6 millions metric tons of crop production is a reason-
able contribution towards 5 billion tons of food produced
annually. Therefore, adoption of GM technology for growing
these crops has already contributed largely to global crop pro-
ductivity and reduced cost productions.
Increasing the income of poor farmers which constitute
50% of world population will go a long way towards reduc-
ing poverty of 70% world poorest people that depend largely
on agriculture for survival. GM crops production has in-
creased the income for more than 90% (13 million) small
scale and resource-poor farmers from developing countries
which have contributed to poverty alleviation in 2008 [66].
James [66] argues that the production of GM cotton in Chi-
na, India and South Africa and GM maize in Philippines and
South Africa have already improved livelihood of 12 million
resource-poor farmers and contributed signiﬁcantly to their
incomes. In future, production of GM rice has potentials to
feed and increase the income of 250 million people in Asia
where some of poorest people live in the world with income
less than US$ 1 a day.
GM technology can provide cost-effective solution to vita-
mins and mineral deﬁciencies by developing rice varieties that
can contain vitamin A and minerals which can solve the prob-
lem of malnutrition in developing countries. For example, the
genetically enriched rice called ‘‘Golden Rice’’ is the vitamin A
improved rice that could alleviate vitamin A deﬁciency in
developing countries [83,90], particularly in South-East Asia
and Africa where vitamin A and malnutrition problem are en-
demic among the children. GM cassava can also provide essen-
tial micronutrients for the young children and pregnant
women as well as improving farmer’s productivity and liveli-
hoods in sub-Saharan Africa. Other orphan crops such as rice,
tropical maize, wheat, sorghum, millet, banana, potato, sweet
potato and oil seed can also beneﬁt from GM technology in
developing countries.
In the context of Millennium Development Goal (MDG-1)
to halve poverty by 2015, improving agricultural productivity
and food security is fundamental to achieve MDG-1. A grow-
ing body of literatures already showed that GM technology
has great potentials to improve agricultural productivity and
it will be one of vital agricultural technologies to reduce pov-
erty in developing countries. GM crops are expected to con-
tribute towards reducing poverty by 50% by 2015 [66]. There
is always need to emphasise that GM technology alone cannot
offer complete solution or a magic bullet for food security
problem, but when combined with a mix of regulated policies,
effective-appropriate institutions, political commitments, pub-
lic and private investments in rural areas, and other agricul-
tural technologies, it could be a powerful tool against
ﬁghting poverty and food insecurity [88].4. Challenges and the way forward
4.1. Constraints in adopting GM crops
Despite the beneﬁts of GM crops over the past decade since
the commercialization started, there are still many challenges
or constraints associated with the adoption of GM technology
across the globe, particularly in developing countries that are
expected to beneﬁt most from this technology (Table 3).
Most developing countries are yet to grow GM crops on
commercial scales due to a number of factors. One of the most
prominent factors is biosafety regulations as most countries
have not fully satisﬁed the requirements for the release of
GMO products, and due to ‘‘go-slow’’ approach toward GM
technology by individual counry government, thus delaying
the commercialization of GM crops. There is lack of proper
coordination and harmonization for developing biosafety regu-
lation in developing countries and this can been seen as slowing
down the growth in international adoption of GM crop innova-
tions [91]. This challenge appears to be the most formidable and
biggest limitation in adoption and growth ofGM crops in devel-
oping world including Africa countries. For example, a change
of administration, political lobbying and lack of priority can de-
lay approval of biosafety regulation in Africa [2].
Africa is arguably oneof themost affected continents due to a
considerable number of factors hindering the development of
GM technology. This is clearly evident as only three African
countries are growing GM crops when compared with other
developing countries. However, different constraints are associ-
atedwith different continents around theworldwhen it comes to
adoption of GM technology, but Africa seems to have a lot
more. It is difﬁcult to argue and attribute a particular constraint
to the adoption of GM technology in Africa but there are
several factors that may be responsible. Africa is poverty
stricken continent where problems like poor governance, politi-
cal crisis, inadequate infrastructures, weak markets, human
immunodeﬁciency virus/acquired immunodeﬁciency syndromes
(HIV/AIDs), malaria and civil war can be taken into account in
adopting GM technology. Moreover, Asia are not exempted
from attributes commonly associated with Africa, South-East
Asia have similar problems that affects the adoption of GM
technology.
The adoption of GM crops between global North and global
South is not evenly distributed geographically, with most adop-
tion coming from global South. As a result, data resulting from
global production of commercial GM crops are sometimes dif-
ﬁcult to analyse. Only few developed countries such as US and
Canada are the dominant producers of GM crops in North
America with outstanding capacity building to support agricul-
tural development.Unlike European countries that are expected
to be among top adopters, only Spain has been consistently pro-
ducing GM crops for over a decade with total production less
than 1 million hectare since the country joined GM producing
countries in 1998, suggesting the inﬂuence of other European
countries on production level. Without a doubt, most European
countries have strong capacity building with a big ﬁnancial
investment to support agricultural development. But, however,
European concerns about the food safety and lack of support for
relevant GM crop policies, particularly based on precautionary
principle are one of main reasons why adoption of GM crop has
been slow [3,26,69].
Table 3 Constraints in the adoption of GM technology in developing countries.
Constraints Country Complex issues arising from adopting GM crops
Regulatory cost India High cost for regulatory process in India (e.g. GM cotton) [93]
Philippine Regulatory delay of GM rice may lead to high cost [4]
Trade concerns Egypt and
South Africa
Fear of European ban on GM products is a major factor for delaying an
approval of GM potato [24,86]
Brazil Fear of losing market in Europe may aﬀect the approval of GM
soybeans [72,85]
Argentina
and China
Commodity export losses to Europe and Japan stopped the approval of
new GM crops by Chinese and Argentina governments in 1998 and
2001, respectively, [20]
India Planting GM rice may lead to European ban, [109] and mandatory
labelling of GM food due to rice import from India to Qatar [73]
Intellectual
property rights
(IPR)
China Local piracy of GM cotton due to weak IPR and lack of access to large
commercial seed market in China [20]
Brazil Black market seeds and smuggling of GM soybean seeds to Brazil from
the border of Argentina due to GM levy as farmers cannot aﬀord high
seed price [97]
Argentina Resource-poor farmers are unwilling to pay for high seed price of GM
cotton despite reduction in pesticide application and increase in yield [95]
India Proposed introduction of IPR form of Variety Genetic Use Restriction
Technologies (V-GURTs) otherwise called terminator genes for seed
sterility was disqualiﬁed in India [87] and was rejected by the
Rockefeller Foundation [102] and by the Consultative Group on
International Agricultural Research (CGIAR) [18]
Safety concerns India Moratorium was placed on the ﬁrst GM eggplant to be commercially
produced due to health reason [4], and alleged complaints were made over
GM cotton due to allergic reactions among GM cotton workers [41]
Brazil Allergic reaction due to the presence of brazil nut gene in GM soybean
led to the research to be stopped on this crop [82]
Mexico GM maize was stopped due to alleged discovery of transgenic DNA in
indigenous maize in 1998 [74]
European
countries
A group of ﬁve European countries which include France, Austria,
Germany, Greece and Luxembourg banned Mosanto’s GM maize
(MON810) due to potential environmental hazard [25]
Anti-GMO
(Genetically
Modiﬁed
Organism)
India GM rice test plots were burnt down by Indian farmers and The All India
Rice Exporter Association (AIREA) were trying to convince governments
to stop GM rice ﬁeld trials in basmati rice growing states [52]
Europe GMO products are prohibited in many places in Europe with GMO-
Free Zone declared in Ireland [84]. A well organised group and leading
European NGO like Greenpeace campaigns vigorously against GM in
developing countries [24,39], including many other NGOs in Europe
and around the world
Source: information in the table was compiled from different sources as shown in the references above.
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in top ﬁve lead developing countries such as Argentina, India,
China, Brazil and South Africa. Several factors underpin high
adoption rate among those ﬁve developing countries. And
some have to do with the fact that the institution building to
promote biotechnology activities are effective and reliable to
a large extent in the ﬁve countries. In addition to that, a lot
of ﬁnancial investment has been made. For example, in Latin
America, Argentina alone is the top producer of GM crops
with 229-fold increase between 1996 and 2010 (Table 1), with
the exception of US. Argentina is known to have invested close
to $US 10 billion on agriculture between 1996 and 1998 to
improve crop biotechnology capacity [55]. China and India
have stood out in Asia for leading commercial GM cropsproduction and these two countries have invested more than
$US 4 billion annually on agricultural development [47,68].
While few countries with considerable scientiﬁc infrastruc-
ture and clear programmes on cutting-edge biotechnology
have translated R&D into signiﬁcant adoption of GM crops
and commercialized some of their products, many countries
in Asia, Latin America and Africa are far from adopting
GM crops that have potential to improve livelihood and in-
crease income of resource-poor farmers. And this is simply be-
cause they lag behind in terms of capacity to produce, regulate
and apply biotechnology in crop productions [6,81]. African
country seems to be the worse among all the countries with
very few institutions dedicated to biotechnology R&D
development. Juma [70] reports that reduction in agricultural
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hence Africa must invest in agricultural R&D, particularly
agricultural biotechnology.
Another major constraint hindering the development of
GM technology in developing countries is lack of ﬁnancial re-
sources to support biotechnology R&D which requires huge
capital to develop and sustain. Genetic engineering research
is very expensive relative to conventional or traditional bio-
technology. For example a genetically modiﬁed potato re-
search cost an average of US$ 2 million when compared to
tissue-culture and marker technology project at an average
of US$ 300,000 [79].
The absence of a well established and enabling policy that
encourage intellectual property rights (IPR) system is also
depriving most developing countries of a proper functioning
commercial market for improved seed varieties. It may be
one of the reasons why biotech industries are not investing
in developing countries due to non-existing IPR and poorly
structured market system. While lack of legal protection for
IPR system is more common in Africa [79], some countries
in Asia (e.g. China) have weak IPR protection [20]. In spite
of beneﬁts that may come from IPR systems, there are con-
cerns that strong IPRs will dominate global food production
by a small biotech industries (e.g. Monsanto) [17,79]. Also,
IPR placing restriction on resource-poor farmers in terms of
their existing rights to store and exchange seed through termi-
nator technology in developing countries, if implemented can
constrain innovations germane to developing countries
(Table 3).
The role of media in the likelihood of adopting GM tech-
nology for agricultural production is very important. But most
media coverage in developing countries have been disappoint-
ing on the issue of GM crops due to lack of analytical report-
ing, lack of balance of views and poor informed debate. For
example, complete rejection of GM food aid from United
States by Zambian Government may have been inﬂuenced
by media involvement, and this can potentially affect govern-
ment decision and policy. Moreover, recent report showed that
much of the media coverage revealed a lack of adequate inves-
tigative reporting on GM debate as most announcements were
based on unreliable sources in developing countries [78]. This
report suggests some weaknesses in the way journalists investi-
gate some science-related issues in most developing countries.
Trade concern is another issue that may delay adoption of
GM technology in developing countries. Perhaps, the inﬂuence
of European Union may be a contributing factor as African,
some Asia and Latin America countries would not like to com-
promise their trade partnership with European countries (Ta-
ble 3). It was reported that Eastern and Southern African
countries showed low interest of GM export market due to
possibility of being rejected by European Union [86]. Cohen
and Paarlberg [20] report that slow adoption of GM technol-
ogy in developing countries can be attributed to commercial
fear, particularly in partnership with European countries and
East Asia. The authors showed the examples of Argentina
and China where approvals for growing some certain GM
crops were delayed in 1998 and 2001, respectively. They con-
clude that fear of losing their export sales to European coun-
tries and East Asia coupled with political matter can
seriously affect the approval of biosafety regulation in devel-
oping countries. The adoption of GM technology in develop-
ing countries is affected by other factors such as low level ofeducation, lack of public awareness, acceptance, international
regulations and many others.
4.2. Policy Implications for the development and adoption of
GM crops
The constraints discussed above are formidable but not invin-
cible. From the collection of summarised activities and infor-
mation on the commercialization of GM crops since 1996, it
possible to synthesize and mention vital policy implications
that will help towards the development of modern biotechnol-
ogy in developing countries as described below.
4.2.1. Provision of functional and appropriate international
regulatory capacity
If adoption of GM technology will mostly and truly beneﬁt
developing countries as being said frequently, something there-
fore must be done about international regulatory capacity. The
lack of an international regulatory capacity is affecting the
development and adoption of GM technology in developing
countries. Moreover, resource-poor farmers are still deprived
of this technology and prevented from achieving innovative
agricultural success [108]. One of the points to reckon with is
the limited adoption of GM crops by small land holders in
most of developing countries. A serious but convincing effort
to help developing countries should be rendered to establish
effective regulatory frame work capacity. In fact, a combined
effort from credible international bodies or agencies is needed
as this is beyond one country approach. The Food and Agri-
culture Organization (FAO), the Organisation for the Eco-
nomic Cooperation and Development (OECD), World Bank
and other relevant agencies can be involved to ensure the effort
becomes a success.
Another point is the current trend to enact highly restrictive
regulations which make it difﬁcult for public institutions in
developing countries to conduct GM ﬁeld trials under local
conditions, thereby affecting the product development. As
time consuming and excessive compliance within the regula-
tions may prevent public institutions from conducting the ﬁeld
tests. Therefore, the developing countries must given the
opportunity to develop GM products to suit their needs while
conducting ﬁeld tests under local conditions.
4.2.2. Educational policies for the interpretation of biosafety
regulation
Lack of educational policies for interpreting biosafety regula-
tion for resource-poor farmers is affecting the adoption of
GM technology in developing countries. Most small-scale
farmers in developing countries have low level of education,
and their inability to read or understand the ofﬁcial language
in which biosafety law is written may lead to wrong applica-
tion of GMO products. For example, commercial production
of GM cotton employed 2–4 million farmers mostly illiterate
in Burkina Faso. Because the level of education among these
farmers is extremely low, particularly reading of Biosafety
Law written in French is a big challenge [51]. To solve this
problem, Biosafety Law was translated into three most com-
monly spoken languages (Moore, Jula and Gulmacema) in cot-
ton growing areas to create awareness on Biosafety Law. The
idea is to promote and enlighten the farmers and local people
about the Biosafety Law. Given low level of education among
resource-poor farmers in developing countries, individual
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that will facilitate the interpretation of national biosafety reg-
ulation in most commonly spoken languages for safe applica-
tion of GMO products.
4.2.3. Transfer of technological innovation
Identifying more efﬁcient ways and means of transferring tech-
nological innovation to developing nations by driving reliable
bioeconomy will create wealth and economic beneﬁts for the
users. The developed countries clearly have important roles to
playwhen transferring technological innovations (e.g.GM tech-
nology) by working in collaboration with international initia-
tives such as the International Service for Acquisition of
Agric-biotech Applications (ISAAA), African Agricultural
Technology Foundation (AATF) and relevant government ini-
tiatives in developing countries. Different agricultural research
organisations and government departments such as Ministry
of Science and Technology, Ministry of Agriculture in devel-
oped and developing countries can work together to establish
a common goal on policy formulation and implementation that
will facilitate and encourage international transfer of technol-
ogy. All OECD countries have to make this a priority if modern
biotechnology will truly have global economic impact as envi-
sioned by early innovators.
4.2.4. Investment in technological innovation and agricultural
research
Agricultural investment plans must be coherent and part of
overall national plans that are clearly spelt out in the budget
for economic development, food security and poverty reduc-
tion in any country. Many people are poor and hungry today
in developing countries due to long-term under-investment in
agriculture particularly in scientiﬁc research and technological
innovation development which is synonymous to African
countries [108]. The authors argue that funding agriculture re-
search will yield proﬁtable returns, and will serve as a powerful
weapon in ﬁghting against poverty and hunger. One key stra-
tegic approach to tackle this constraint in the area of scientiﬁc
research and technological innovation is to invest in biotech-
nology R&D in developing countries.
Before it can be a viable biotechnology R&D through ade-
quate investments as described byADB [1], it will have to satisfy
the following four attributes: (1) it must address both the prob-
lems of small farmers in rainfed areas where majority of poor
live, and those of small farmers in irrigated areas that provide
bulk of food grain in Africa and Asia; (2) Priority should be
placed on orphan crops such as rice, tropical maize, wheat, sor-
ghum, millet, banana, oilseed, potato and sweet potato. Bio-
technology R&D should also focus on high value commodity
crops such as cotton, soybean and vegetables that can increase
resource-poor farmers income through crop diversiﬁcation; (3)
The development and provision of technology for resource-poor
farmers must be simple, low cost with little or no risk to human
health and environment; (4) Biotechnology development should
be accompanied by welcoming policy environment that reﬂect
transparent governance, rural infrastructural development, efﬁ-
cient agricultural extension services and reliable credit and
marketing.
Although, lack of ﬁnancial resources are hampering the
development of biotechnology R&D in some of developing
countries, in that situation, the governments should set a speciﬁc
goal clearly underlined in biotechnology R&D, supported withreliable policy and some level of commitment that will attract
some foreign donors to support and invest in their program.
4.2.5. Increase access to information resources
Adequate and free access to information resources on technol-
ogy that still requires a lot to learn or know about it should not
be conﬁned to a small group. Many developing countries, par-
ticularly in public research institutions do not have access to
vital information that could improve their understanding on
GM technology. Some access problems relate to data collec-
tion, management and storage such as availability of systems
for reliable sample and data tracking, or access to modern ana-
lytical methodologies and tools for accurate decision-making,
amongst others. Even though, there is still much sharing for re-
search purpose, but access to biotech research is restricted by
one or more material-transfer agreements, which further re-
strict distribution and commercialization.
Also, restricting information from the data on the perfor-
mance of biotechnical products by private sector is another
concern, and this sometimes makes it difﬁcult for the analysis
of policy issues. This is in sharp contrast to previous epochs of
technical change including the green revolution, in which pub-
licly funded research led to public data availability. The most
immediate policy need is perhaps, to provide transparent and
efﬁcient means of data dissemination that can facilitate quan-
titative assessment of the potential of biotechnology. More
importantly, the developed country like US needs to take the
lead as integral part of the sector in conjunction with interna-
tional communities towards creating a welcoming policy envi-
ronment that will encourage more access to information on
biotechnology R&D in developing countries at little or no cost
or through reformed public–private partnership.
5. Conclusion
In summary, steady growth of GM crops in the past 15 years
have shown that GM technology has a great potential towards
contributing to sustainable agriculture, particularly in develop-
ing countries. Moreover, the global beneﬁt of GM crops have
made signiﬁcant difference in terms of cost savings, increases
in yield and proﬁtability, improving the quality of life and reduc-
ing the use of pesticide and herbicide. This in turn leads to a sig-
niﬁcant saving on fossil fuels and lowering carbon dioxide
emissions, thereby mitigating climate change. According to
James [66], more countries from different continents including
Africa, Asia, Latin and Central America and Caribbean are ex-
pected to join GM producing countries on a commercial basis,
and countries are expected to reach 40 or over by the year
2015 with about 20million farmers cultivating GM crops across
the globe. In the last few years supports forGMcrops have come
from different sections of life such as political leaders (e.g. G8
leaders), scientists, world reputed scholars, including policy
makers and leaders from developing countries [19,33,66], sug-
gesting that beneﬁts of GM technology are being recognised.
The world needs fast and reliable solutions to fast growing
population and the problems of hunger, malnutrition, ravag-
ing diseases, poverty and global warming crisis. One of ideal
technological innovations such as GM technology can be part
of solutions to these problems. It is imperative to understand
that GM technology cannot establish its ground if continu-
ously faced with the baggage of constraints as discussed in Sec-
tion 4.1 above. Moreover, it is not surprising to gather from a
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capacity building and still struggling with the establishment
of biosafety system that can facilitate GM ﬁeld trials and com-
mercial release of GM products. Some of the challenges asso-
ciated with the development of modern biotechnology still boil
down to the fact that individual country government and inter-
national organisations have not clearly identiﬁed a coherent
strategy and enabling policy instrument to deal with the prob-
lems. While some progress have been made on GM technology
in terms of research and development, capacity building, and
biosafety regulation in developed countries and a few develop-
ing countries, concerted effort is still needed to make it an
accessible technology for every country.
Finally, the world of agricultural biotechnology should be
appreciated while assessing its potentials and global impact in
the last 15 years. More attention should be paid to the improve-
ment of GM technology to harness its maximum potentials as
well as taking case-by-case cautious regulatory approach [27],
while considering future potential risks. All relevant institutions
that include individual country government, private and public
sector and international agencies should work together to en-
sure that everyone beneﬁts from GM technology, particularly
in developing countries. Therefore, the developing world if not
entireworld needGMtechnology andmust not be ignored,mar-
ginalised or sidelined, because it has the weapons to ﬁght pov-
erty, reduce malnutrition and hunger, improve food security,
create friendly environments, increase the income of poor farm-
ers and beneﬁt society as a whole.Acknowledgment
The author acknowledges the support of the Japan Society for
the Promotion of Sciences (JSPS). Special thanks to Janet E.
Carpenter for corrections and insightful comments.References
[1] ADB, Agricultural Biotechnology Poverty Reduction and
Food Security, Asian Development Bank (ADB), Working
Paper, 2001.
[2] A.A. Adenle, Nigeria must press ahead with GM crops: science
and Innovation Policy, SciDev.Net April 27, 2011.
[3] I.S. Arvanitoyannis, P. Tserkezou, T. Varzakas, Int. J. Food
Sci. Technol. 41 (2006) 130–159.
[4] J.C. Bayer, G.W. Norton, J.B. Falck-Zepeda, AgBioForum 13
(2010) 53–62.
[5] R. Bennett, S. Morse, Y. Ismael, Outlook Agric. 32 (2003) 123.
[6] T. Berg, M. Syed, H.G.O. Ferstad, B. Tsegaye, A. Waktola,
Why are developing countries falling behind in biotechnology?
Center for International Environment and Development
Studies, Nairobi, Kenya, 2003.
[7] J.C. Bernard, J. Pesek, C. Fan, Agric. Resour. Econ. Rev. 33
(2004) 282–292.
[8] BMA, British Medical Association (BMA), Genetically
Modiﬁed Foods and Health: A Second Interim Statement.
British Medication Association, March 2004. Available from:
<http://www.bma.org.uk/health_promotion_ethics/
nutrition_exercise/GMFoods.jsp>.
[9] G. Brookes, AgBioForum 8 (2005) 235–241.
[10] G. Brookes, Int. J. Biotechnol. 10 (2008) 148–166.
[11] G. Brookes, P. Barfoot, AgBioForum 9 (2007) 139–151.
[12] G. Brookes, P. Barfoot, AgBioForum 13 (2010) 76–94.[13] G. Brookes, P. Barfoot, GM Crops: Global Socio-Economic
and Environmental Impacts 1996–2008, PG Economics Ltd.,
UK, 2010.
[14] J.E. Carpenter, Nat. Biotechnol. 28 (2010) 319–321.
[15] J.E. Carpenter, Landes Biosci. 2 (2011) 1–17.
[16] M. Cattaneo, C. Yafuso, C. Schimidt, C. Huang, M. Rahman,
C. Olson, C. Ellers-Kirk, B. Orr, S. Marsh, L. Antilla, P.
Dutilleul, Y. Carriere, Proc. Natl. Acad. Sci. USA 103 (2006)
7571–7576.
[17] J. Cayford, Issues Sci. Technol. (2004) 46–59.
[18] CGIAR, ‘‘Shaping the CGIAR’s future: summary of proceedings
and decisions’’ Consultative Group on International Agricultural
Research (CGIAR) International Center Week, October 26–30,
CGIAR Secretariat, Washington, DC, 1998.
[19] C. Clive, A time to sow? GM food could curb the cost of
staples, Financial Times, July 10, 2008.
[20] J.I. Cohen, R. Paarlberg, AgBio-techNet 4 (2002).
[21] A.J. Connor, R.G. Travis, J.P. Nap, Plant J. 33 (2003) 19–46.
[22] G. Conway, The Doubly Green Revolution: Food for all in the
21st Century, Penguin Books, Cornell University Press,
London, Ithaca, NY, 1999.
[23] G. Conway, G. Toenniessen, Nature 402 (1999) 55.
[24] J.G. Cooke, R. Downie, African Perspectives on Genetically
Modiﬁed Crops: Assessing the Debate in Zambia, Kenya, and
South Africa; A Report of the CSIS Global Food Security
Project, Center for Strategic and International Studies (CSIS),
2010.
[25] S. Das, France’s GM ban set to hurt Indian food exports, The
Financial Express, 2009. Available from: <http://www.
ﬁnancialexpress.com/news/frances-gm-ban-set-to-hurt-indian-
food-exports/535891/0>.
[26] EuropaBio, Eur. Assoc. Bioind. (2010).
[27] FAO, Food and Agriculture Organization of the United
Nations, Statement on Biotechnology, March 2000. Available
from: <http://www.fao.org/WAICENT/OIS/PRESS_NE/
PRESSENG/2000/pren0017.htm>.
[28] FAO, Food and Agriculture Organization (FAO) of the United
Nations. The State of Food and Agriculture 2003–04:
Agricultural Biotechnology: Meeting the Needs of the Poor?
FAO, 2004. Available from: <http://www.fao.org/docrep/006/
Y5160E/Y5160E00.HTM>.
[29] FAO, World Hunger Educ. Serv. (2010).
[30] FAO, World agriculture: towards 2030/2050: Interim Report,
2006. Available from: <http://www.fao.org/docrep/009/a0607e/
a0607e00.HTM>.
[31] G.P. Fitt, ‘Implementation and impact of transgenic Bt cottons
in Australia’ The ICAC Recorded, vol. 21, 2003, pp.14–119.
[32] L. Folcher, M. Delos, E. Marengue, M. Jarry, A.
Weissenberger, N. Eychenne, C. Regnault-Roger, Agron
Sustainable Dev. 10 (2010) 1051.
[33] G8, Reporter’s Notebook, G8 Leaders Call for Increased
Global Access to Agricultural Biotechnology, Council for
Biotechnology Information, July 2008. Available from:
<http://www.whybiotech.com/newsandevents/reportersnote
book/0708/index_070908.asp>.
[34] L.P. Giannesi, J.E. Carpenter, Agricultural biotechnology:
Beneﬁts of transgenic soybeans, National Center for Food and
Agricultural Policy, Washington, DC, 2000.
[35] H.C. Godfray, J.R. Beddington, I.R. Crute, L. Haddad, D.
Lawrence, J.F. Muir, J. Pretty, S. Robinson, S.M. Thomas, C.
Toulmin, Science 327 (2010) 812–818.
[36] M. Gomez-Barbero, E. Rodriguez-Cerezo, GM crops in EU
Agriculture, European Commission, DG-JRC, Institute for
Prospective Technology Studies, Seville, 2007.
[37] M. Gouse, C. Pray, J. Kirsten, D. Schimmelpfening, Int. J.
Biotechnol. 7 (2005) 84–94.
[38] M. Gouse, J. Piesse, C. Thirstle, C. Poulton, AgBioForum 12
(2009) 78–89.
94 A.A. Adenle[39] Green, Contamination by Genetically Modiﬁed Papaya in
Thailand, Greenpeace South Asia, Report, May 2006.
[40] J. Gressel, A. Hanaﬁ, G. Head, W. Marasas, A.B. Obilana, J.
Ochanda, T. Souissi, G. Tzotzos, Crop Prot. 23 (2004) 661–689.
[41] A. Gupta, ‘‘Impact of Bt Cotton on Farmers’ Health (in
Barwani and Dhar District of Madhya Predesh),’’ Investigation
Report, October–December 2005.
[42] B. Hammond, K. Campbell, C. Pilcher, T. Degooyer, A.
Robinson, B. McMillen, S. Spangler, S. Riodan, L. Rice, J.
Richard, J. Agric. Food. Chem. 52 (2004) 1390–1397.
[43] R. Hautea, M. Escaler, AgBioForum 7 (2004) 2–8.
[44] H.W. Heldt, Are there Hazards for the Consumer when Eating
Food from Genetically Modiﬁed Plants? Union of the German
Academies of Science and Humanities, Commission on Green
Biotechnology, Universitat Gottingen, 2004. Available from:
<http://www.akademienunion.de/pressemitteilungen/2006-06/
english.html>.
[45] R.J. Herring, J. Dev. Stud. 43 (2007) 130–157.
[46] J. Huang, R. Hu, C. Pray, F. Quiao, S. Rozelle, Biotechnology
as an alternative to chemical pesticides: a case study of Bt
cotton in China, in: Fifth Inter. Consortium Ag. Biotech. Res.,
Ravello, Italy, June 15–18, 2001, pp. 109–110.
[47] J. Huang, S. Rozelle, C. Pray, Q. Wang, Science 295 (2002)
674–676.
[48] J. Huang, C. Pray, S. Rozelle, Nature 418 (2002) 678–684.
[49] J. Huang, R. Hu, S. Rozelle, C. Pray, Science 308 (2005).
[50] J. Huesing, L. English, AgBioForum 7 (2004) 87–95.
[51] ISAAA, International Service for the Aquisition of Agri-
Biotech Applications: Crop Biotech Update, Newsletter, 2010.
[52] ISIS, Global GM Crops Area Exaggerated, Institute of Science
in Society, ISIS Press Report, 2007.
[53] Y. Ismael, R. Bennett, S. Morse, Biotechnol. Dev. Monit.
(2001) 15–19.
[54] C. James, Global Status of Commercialized Biotech/GM Crops:
1997 (ISAAA Brief No. 5), International Service for the
Acquisition of Agri-biotech Applications, Ithaca, NY, 1997.
[55] C. James, Global Status of Commercialized Biotech/GM Crops:
1998 (ISAAA Brief No. 8), International Service for the
Acquisition of Agri-biotech Applications, Ithaca, NY, 1998.
[56] C. James, Global Status of Commercialized Biotech/GM Crops:
1999 (ISAAA Brief No.12), International Service for the
Acquisition of Agri-biotech Applications, Ithaca, NY, 1999.
[57] C. James, Global Status of Commercialized Biotech/GM Crops:
2000 (ISAAA Brief No. 21), International Service for the
Acquisition of Agri-biotech Applications, Ithaca, NY, 2000.
[58] C. James, Global Status of Commercialized Biotech/GM Crops:
2001 (ISAAA Brief No. 24), International Service for the
Acquisition of Agri-biotech Applications, Ithaca, NY, 2001.
[59] C. James, Global Status of Commercialized Biotech/GM Crops:
2002 (ISAAA Brief No. 27), International Service for the
Acquisition of Agri-biotech Applications, Ithaca, NY, 2002.
[60] C. James, Global Status of Commercialized Biotech/GM Crops:
2003 (ISAAA Brief No. 30), International Service for the
Acquisition of Agri-biotech Applications, Ithaca, NY, 2003.
[61] C. James, Global Status of Commercialized Biotech/GM Crops:
2004 (ISAAA Brief No.32), International Service for the
Acquisition of Agri-biotech Applications, Ithaca, NY, 2004.
[62] C. James, Global Status of Commercialized Biotech/GM
Crops: 2005 (ISAAA Brief No.34), International Service for
the Acquisition of Agri-biotech Applications, Ithaca, NY,
2005.
[63] C. James, Global Status of Commercialized Biotech/GM Crops:
2006 (ISAAA Brief No. 35), International Service for the
Acquisition of Agri-biotech Applications, Ithaca, NY, 2006.
[64] C. James, Global Status of Commercialized Biotech/GM Crops:
2007 (ISAAA Brief No. 37), International Service for the
Acquisition of Agri-biotech Applications, Ithaca, NY, 2007.[65] C. James, Global Status of Commercialized Biotech/GM Crops:
2008 (ISAAA Brief No. 39), International Service for the
Acquisition of Agri-biotech Applications, Ithaca, NY, 2008.
[66] C. James, Global Status of Commercialized Biotech/GM Crops:
2009 (ISAAA Brief No. 41), International Service for the
Acquisition of Agri-biotech Applications, Ithaca, NY, 2009.
[67] C. James, Global Status of Commercialized Biotech/GM Crops:
2010 (ISAAA Brief No.42), International Service for the
Acquisition of Agri-biotech Applications, Ithaca, NY, 2010.
[68] A. Jamwal, U.M. Ohndorf, F. Boeuf, D. Herman, Bio-Visions
2015: Scenarios for Biotechnology (A Report), Siemens AG,
Munich, 2006.
[69] H.T. Jensen, H.G. Jensen, M. Gylling, Adoption of GM Food
Crop Varieties in the European Union, Institute of Food and
Resource Economics, University of Copenhagen, 2009.
Available from: <http://www.gtap.agecon.purdue.edu/
resources/download/4765.pdf>.
[70] C. Juma, The New Harvest, Agricultural Innovation in Africa,
Oxford University Press, 2011.
[71] M. Karembu, F. Nguthi, H. Ismali, Biotech crops in Africa:
The Final Frontier, ISAAA AfriCenter, Nairobi, Kenya, 2009.
[72] L. Kent, AgBioForum 7 (2004) 63–69.
[73] E. Landais, Gulf News (2007).
[74] U. Lele, Am. J. Agric. Eco. 85 (2003) 1119–1125.
[75] R. Luther, K. Tucker, AgBioForum 5 (2002) 59–64.
[76] D. Makinde, L. Mumba, A. Ambali, Asian Biotechnol. Dev.
Rev. 11 (2009) 1–10.
[77] M.P. Marra, P. Pardey, J. Alston, AgBioForum 5 (2002) 43–50.
[78] E. Mashood, The GM Debate-Who Decides? Analysis of
decision-making about genetically modiﬁed crops in
developing countries, Panos Report No 49. (2004).
[79] M. Millers, ‘‘Genetically modiﬁed crops in Africa’’, in: J. Cutler
(Eds.), Encyclopedia of Earth, Cleveland, 2007 (Washington,
DC: Environmental Information Coalition, National Council
for Science and the Environment).
[80] S. Morse, R. Bennett, Y. Ismael, Int. J. Biotechnol. 7 (2005)
72–83.
[81] J. Mugabe, Biotechnology in developing countries and countries
with economies: strategic capacity building considerations,
African Centre for Technology Studies, Nairobi, Kenya, 2000.
[82] J.A. Nordlee, N. Engl. J. Med. 334 (1996) 688–692.
[83] D. Normile, Science 289 (2000) 843–845.
[84] M. O‘Callaghan, Banning GM Food and Crops in Europe,
GM-Free Ireland Network, Dail Brieﬁng on GMO Policy, 15
June 2005.
[85] R. Paarlberg, The Global Food Fight, Foreign Affairs May/
June, pp. 24–38, 2000.
[86] R. Paarlberg, Int. J. Technol. Global. 2 (2006) 81–92.
[87] C.N. Pedleton, Biotechnol. Law Rep. 23 (2004) 1–29.
[88] G.J. Persley, M.M. Lantin (Eds.) Agricultural Biotechnology
and Poor, in: Proceedings of an International Conference on
Biotechnology, Washington, DC, 21–22 October 1999,
Consultative Group on International Agriculture Research,
Washington, DC, 2000.
[89] P. Pinstrup-Andersen, Selected Aspects of the Future Global
Food Situation, 25th IFA Enlarged Council Meeting, Rome,
30 November–3 December 1999.
[90] I. Potrykus, Plant Physiol. 125 (2001) 1157–1161.
[91] I. Potrykus, GMO-projects for public goods are faced with
prohibitive conditions. Paper Presented at the 13th ICABR
Conference, Ravello, Italy 2009.
[92] C.E. Pray, J. Huang, R. Hu, S. Rozelle, Plant J. 31 (2002) 423–
430.
[93] C. Pray, P. Bengali, B. Ramaswami, Q. J. Int. Agric. 44 (2005)
267–289.
[94] M. Qaim, Ann. Rev. Resour. Econ. 2009 (2009) 665–693.
[95] M. Qaim, A. De Janvry, Am. J. Agric. Eco. 85 (2003) 814–824.
Global capture of crop biotechnology in developing world over a decade 95[96] M. Qaim, A. De Janvry, Environ. Dev. Econ. 10 (2005) 179–200.
[97] M. Qaim, G. Traxler, Agric. Econ. 32 (2005) 76–86.
[98] M. Qaim, D. Zilberman, Science 299 (2003) 900–902.
[99] A. Qayum, K. Sakkhari, Bt Cotton in Andhra Pradesh A
Three-year Assessment, The First Ever Sustained Independent
Scientiﬁc Study of Bt Cotton in India, Deccan Development
Society, Andhra Pradesh Coalition in Defense of Diversity,
Permaculture Association of India, 2005.
[100] T. Raney, Curr. Opin. Biotechnol. 17 (2006) 1–5.
[101] K. Redenbaugh, M. Hiatt, B. Martineau, M. Kramer, R.
Sheehy, R. Sanders, C. Houck, D. Emlay, Safety Assessment of
Genetically Engineered Fruits and Vegetables; A Case Study of
the FLAVR SAVRTM Tomato, CRC Press, Boca Raton, FL,
1992.
[102] RF, Rockefeller Foundation ‘‘Food gains for the world’s poor
are being threatened by furor over genetically modiﬁed (GM)
foods’’, Press release, Rockefeller Foundation, Washington,
DC, 1999.
[103] W. Roca, C. Espinoza, A. Panta, AgBioForum 7 (2004) 13–22.
[104] M.W. Rosegrant, P.B.R. Hazell, Transforming the rural Asian
economy: the unﬁnished revolution (2020 Vision Brief 69).
Washington, DC: International Food Policy Research
Institute, 2001. Available from: <http://www.ifpri.org/2020/
briefs/number69.htm>.
[105] RS, Where is the Evidence that GM Foods are Inherently
Unsafe, Asks Royal Society. Press release, Royal Society (RS), 8
May, 2003. Available from: <http://royalsociety.org>/
<http://royalsociety.org>/Submission-to-the-Governments-
GM-Science-Review/<http://royalsociety.org>/GM-crops-
modern-agriculture-and-the-environment—Report-of-a-Royal-
Society-Discussion-Meeting-held-on-11-February-2003/.[106] V.W. Ruttan, AgBioForum 2 (1999) 54–60.
[107] O. Sanvido, J. Romeis, F. Bigler, Adv. Biochem. Eng.
Biotechnol. 107 (2007) 235–278.
[108] I. Scoones, D. Glover, Nature 460 (2009) 797–798.
[109] A. Sharma, Moratorium on GM Crops Sought, The Financial
Express, December 2, 2006.
[110] H.C. Sharma, J.H. Crouch, K.K. Sharma, N. Seetharama, C.T.
Hash, Plant Sci. 163 (2002) 381–395.
[111] S. Stone, A. Matysek, A. Dooling, Modelling Possible Impacts
of GM crops on Australian Trade, Staff Research Paper,
Productivity Commission, Melbourne, 2002.
[112] C. Thirstle, L. Beyers, Y. Ismael, J. Piesse, World Dev. 31
(2003).
[113] G. Traxler, S. Godoy-Avila, AgBioForum 7 (2004) 57–62.
[114] W.P. Williams, G.L. Windham, P.M. Buckley, J.M. Perkins,
Field Crops Res. 91 (2005) 329–336.
[115] F. Wu, Perspect. Agric. Vet. Sci. Nutr. Nat. Resour. 2 (2007) 1–
8.
[116] J. Yang, J.W. Kloepper, C.M. Ryu, Trends Plant Sci. 14 (2009)
1–4.
[117] R.H. Zhou, Z.C. Zhang, Q. Wu, R.X. Fang, K.Q. Mang, Y.C.
Tian, Large-scale performance of transgenic tobacco plants
resistant to both tobacco mosaic virus and cucumber mosaic
virus, in: D.D. Jones (Ed.), Proceedings of the Third
International Symposium on the Biosafety Results of Field
Tests of Genetically Modiﬁed Plants and Micro-organisms,
University of California, Oakland, CA, 1995, pp. 49–55.
[118] D. Zilberman, H. Ameden, M. Qaim, J. Dev. Stud. 43 (2007)
63–78.
